Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5625064 | Alzheimer's & Dementia | 2010 | 8 Pages |
Abstract
Different information sources yield widely varied prevalence and expenditure estimates. Although claims data provided a more objective means for identifying AD cases, survey report identified more cases, and pharmacy data also are an important source for case ascertainment. Using any single source will underestimate the prevalence and associated cost of AD. The wide range of AD cases identified by using different data sources demands caution interpreting cost-of-illness studies using single data sources.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Pei-Jung Lin, Daniel I. Kaufer, Matthew L. Maciejewski, Rahul Ganguly, John E. Paul, Andrea K. Biddle,